Answers are grounded in this paper and cite their sources.
SummaryForty-two patients, 21 suffering from rheumatoid disease and 21 from osteoarthrosis, took part in a study to compare the efficacy of flurbiprofen at three dosage levels, namely 75 mg, 150 mg and 300 mg daily, each for 4 weeks. The two disease categories were analyzed separately. For the patients with rheumatoid disease, 2 were removed from the analysis completely and of the remaining 19, 12 were included in all the comparisons and 7 were only included in some. For patients with osteoarthrosis, 2 were removed from the analysis completely and of the remaining 19, 13 were included in all comparisons and 6 were only included in some. For both the patients with rheumatoid disease and those with osteoarthrosis, no significant differences were found between treatments for any of the comparisons, except for the left knee-sternum distances for patients with osteoarthrosis. Here the results showed a significant difference between the 75 mg and 300 mg treatments at the 5% level in favour of the 75 mg treatment. For the patients with rheumatoid disease, severity of pain, grip strength and joint score showed significant improvements from pre-trial values for all three treatments. Duration of morning stiffness showed an improvement for the 75 mg treatment. For the patients with osteoarthrosis, a significant improvement from pre-trial values in severity of pain was seen for all three treatments. Night pain showed a significant improvement for the 300 mg treatment, left knee-sternum distance showed a significant improvement for the 75 mg treatment and the difference between upper and lower values of intermalleolar straddle showed a significant increase from pre-trial values for the 300 mg treatment. Side-effects reported were few in number, minor in nature, and did not appear to be dose related.
No takes yet. Share an insight, caveat, or question.
N Cardoe (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: